On the Record · Moderna
Moderna competitors, on the record
The companies Moderna names as competitors in its annual reports, 2023 to 2025, and the companies that name Moderna, each with the sentence and the filing.
Who Moderna names
| Company | Named in |
|---|---|
| BioNTech | 2025 |
| GlaxoSmithKline | 2025 |
| Novavax | 2025 |
| Pfizer | 2025 |
| Sanofi | 2025 |
In its own words
BioNTech, Pfizer
Word for word“We largely compete against Pfizer and BioNTech for sales of our COVID vaccines, whose vaccine is also based on mRNA technology.” 10-K for 2025
GlaxoSmithKline
Word for word“With respect to our RSV vaccine, we compete against Pfizer and GlaxoSmithKline, who entered the U.S. market prior to us, and our RSV sales have been minimal to date.” 10-K for 2025
Novavax, Sanofi
Word for word“We also compete against other vaccines, including Sanofi and Novavax’s.” 10-K for 2025
Who names Moderna
Companies whose own annual reports name Moderna as a competitor.
Word for word“A number of competitors currently have programs to develop COVID-19 vaccine candidates, including vaccines developed by Moderna, Inc. and Novavax, Inc .” 20-F for 2025
Word for word“Several competitors are working on developing seasonal influenza vaccines using different technologies than those in existing marketed vaccines, the most notable being mRNA from companies including Moderna and Pfizer.” 10-K for 2025
Read from Moderna’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.